Stroke therapy

Carolyn D Brockington MD (

Dr. Brockington, Director of the Stroke Center at Mount Sinai St. Luke’s and Mount Sinai Hospital has no relevant financial relationships to disclose.

)
Steven R Levine MD, editor. (

Dr. Levine of the SUNY Health Science Center at Brooklyn has no relevant financial relationships to disclose.

)
Originally released August 14, 2001; last updated January 14, 2019; expires January 14, 2022

Overview

The treatment of acute ischemic stroke is considered an emergency. The clock starts with the interruption of blood flow to the brain. The goal of each therapeutic intervention is to reestablish blood flow to viable brain tissue to reduce the degree of injury. Since the FDA approval of intravenous tPA for acute ischemic stroke in 1996, the options for treatment have increased considerably. Despite the advances, the key to good clinical outcomes remains the same with rapid identification of patients coupled with fast assessment and treatment. This update contains the latest information on the treatment and management of acute ischemic stroke.

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.